Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Infection and Immunity|February 21, 2002
Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coliJianmei Yu, Frederick Cassels, Tanya Scharton-Kersten, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 6, 2017
Oncolytic VSV Primes Differential Responses to Immuno-oncology TherapyNicholas M Durham, Kathy Mulgrew, Kelly McGlinchey, et al.
Mabs|December 9, 2014
CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomasMichael D Oberst, Stacy Fuhrmann, Kathy Mulgrew, et al.
International Archives of Allergy and Immunology|May 24, 2014
The immune microenvironment: a major player in human cancersW H Fridman, R Remark, J Goc, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
Strictly target cell-dependent activation of T cells by bispecific single-chain antibody constructs of the BiTE classKlaus Brischwein, Larissa Parr, Stefan Pflanz, et al.
Cancer Research|April 19, 2007
Selective targeting and potent control of tumor growth using an EphA2/CD3-Bispecific single-chain antibody constructScott A Hammond, Ralf Lutterbuese, Shannon Roff, et al.
Plos One|May 11, 2012
The CEA/CD3-bispecific antibody MEDI-565 (MT111) binds a nonlinear epitope in the full-length but not a short splice variant of CEALi Peng, Michael D Oberst, Jiaqi Huang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2009
Potent control of tumor growth by CEA/CD3-bispecific single-chain antibody constructs that are not competitively inhibited by soluble CEARalf Lutterbuese, Tobias Raum, Roman Kischel, et al.
Oncoimmunology|November 21, 2015
A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4<sup>+</sup> T cell receptor repertoire clonalityWei Zhu, Claire Germain, Zheng Liu, et al.
Cancer Immunology Research|August 30, 2017
Concurrent PD-1 Blockade Negates the Effects of OX40 Agonist Antibody in Combination Immunotherapy through Inducing T-cell ApoptosisRajeev K Shrimali, Shamim Ahmad, Vivek Verma, et al.
Pageof 5